Ireland - English - HPRA (Health Products Regulatory Authority)

interchem ireland ltd - trimethoprim, sulfadiazine - solution for injection - 40 mg/ml - sulfonamides and trimethoprim - bovine, porcine - antibacterial

Ireland - English - HPRA (Health Products Regulatory Authority)

norbrook laboratories limited - trimethoprim; sulfadiazine - oral paste - percent - sulfonamides and trimethoprim - horses - antibacterial

Ireland - English - HPRA (Health Products Regulatory Authority)

interchem ireland ltd - trimethoprim; sulfadiazine - solution for injection - 40, 200 milligram(s)/millilitre - sulfonamides and trimethoprim - cattle, pigs - antibacterial

Ireland - English - HPRA (Health Products Regulatory Authority)

norbrook laboratories (ireland) limited - trimethoprim; sulfadiazine - oral paste - 5.8, 28.83 percent weight/weight - sulfonamides and trimethoprim

Kenya - English - Pharmacy and Poisons Board

alfasan international kuipersweg 9 - 3449 ja woerden holland netherlands - trimethoprim and sulfadiazine sodium - powder for oral solution in sachet - 80 mg trimethoprim and 400 mg of sulfadiazine… - antibacterials for systemic use: quinolone

United States - English - NLM (National Library of Medicine)

stat rx usa llc - silver sulfadiazine (unii: w46jy43ejr) (sulfadiazine - unii:0n7609k889) - silver sulfadiazine 10 g in 1000 g - silver sulfadiazine cream is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns. silver sulfadiazine cream is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation. because sulfonamide therapy is known to increase the possibility of kernicterus, silver sulfadiazine cream should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life.

United States - English - NLM (National Library of Medicine)

central texas community health centers - silver sulfadiazine (unii: w46jy43ejr) (sulfadiazine - unii:0n7609k889) - silver sulfadiazine 10 mg in 1 g - silvadene cream 1% (silver sulfadiazine) is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second- and third-degree burns. silvadene cream 1% (silver sulfadiazine) is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation. because sulfonamide therapy is known to increase the possibility of kernicterus, silvadene cream 1% should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life.

United States - English - NLM (National Library of Medicine)

ascend laboratories, llc - silver sulfadiazine (unii: w46jy43ejr) (sulfadiazine - unii:0n7609k889) - silver sulfadiazine 10 mg in 1 g -      silver sulfadiazine cream, usp 1% is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns.      silver sulfadiazine cream, usp 1% is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation.      because sulfonamide therapy is known to increase the possibility of kernicterus, silver sulfadiazine cream, usp 1% should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life.      geriatric use. of the total number of subjects in clinical studies of silver sulfadiazine cream, usp 1% seven percent were 65 years of age and over. no overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater s

United States - English - NLM (National Library of Medicine)

proficient rx lp - silver sulfadiazine (unii: w46jy43ejr) (sulfadiazine - unii:0n7609k889) - silver sulfadiazine 10 mg in 1 g - silver sulfadiazine cream, usp 1% is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns. silver sulfadiazine cream, usp 1% is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation.      because sulfonamide therapy is known to increase the possibility of kernicterus, silver sulfadiazine cream, usp 1% should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life. geriatric use. of the total number of subjects in clinical studies of silver sulfadiazine cream, usp 1% seven percent were 65 years of age and over. no overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out. pediatric use. safety and effectiveness in children have not been established. (see contraindications).

United States - English - NLM (National Library of Medicine)

a-s medication solutions - silver sulfadiazine (unii: w46jy43ejr) (sulfadiazine - unii:0n7609k889) - silver sulfadiazine 10 mg in 1 g -      silver sulfadiazine cream, usp 1% is a topical antimicrobial drug indicated as an adjunct for the prevention and treatment of wound sepsis in patients with second and third degree burns.      silver sulfadiazine cream, usp 1% is contraindicated in patients who are hypersensitive to silver sulfadiazine or any of the other ingredients in the preparation.      because sulfonamide therapy is known to increase the possibility of kernicterus, silver sulfadiazine cream, usp 1% should not be used on pregnant women approaching or at term, on premature infants, or on newborn infants during the first 2 months of life.      geriatric use. of the total number of subjects in clinical studies of silver sulfadiazine cream, usp 1% seven percent were 65 years of age and over. no overall differences in safety or effectiveness were observed between these subjects and younger subjects, and other reported clinical experience has not identified differences in responses between the elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out.      pediatric use. safety and effectiveness in children have not been established. (see contraindications)